Randomized, Crossover Study of the Antithrombotic Effects of Ticagrelor Plus Aspirin Versus Clopidogrel Plus Aspirin When Administered With Bivalirudin

Trial Profile

Randomized, Crossover Study of the Antithrombotic Effects of Ticagrelor Plus Aspirin Versus Clopidogrel Plus Aspirin When Administered With Bivalirudin

Completed
Phase of Trial: Phase IV

Latest Information Update: 13 Jul 2016

At a glance

  • Drugs Ticagrelor (Primary) ; Aspirin; Bivalirudin; Clopidogrel
  • Indications Acute coronary syndromes; Thrombosis
  • Focus Pharmacodynamics
  • Most Recent Events

    • 31 Mar 2014 Primary endpoint 'Coagulation-parameters' has been met.
    • 31 Mar 2014 Results presented at the 63rd Annual Scientific Session of the American College of Cardiology.
    • 16 Jan 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top